Akero Therapeutics, Inc. - Common Stock (NQ:AKRO)

54.28 -0.03 (-0.05%)

Streaming Delayed Price Updated: 3:39 PM EST, Nov 24, 2025 Add to My Watchlist

Price and Volume

Volume	1,135,040
Open	54.32
Bid (Size)	54.28 (1,100)
Ask (Size)	54.29 (900)
Prev. Close	54.31
Today's Range	54.28 - 54.41
52wk Range	21.34 - 58.40
Shares Outstanding	50,086,978
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halper Sadeh LLC Encourages SEE, AXTA, SEMR, AKRO Shareholders to Contact the Firm to Discuss Their Rights

November 20, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO

November 20, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Performance

YTD	+93.3%	+93.3%
1 Month	+1.0%	+1.0%
3 Month	+15.4%	+15.4%
6 Month	+18.0%	+18.0%
1 Year	+70.9%	+70.9%

More News

Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith ↗

November 09, 2025

Via Stocktwits

Halper Sadeh LLC Encourages JAMF, CADE, AKRO, GES Shareholders to Contact the Firm to Discuss Their Rights

November 07, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025

November 07, 2025

From Akero Therapeutics Inc.

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qorvo, Inc. (Nasdaq – QRVO), First Foundation Inc. (NYSE – FFWM), Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD)

November 06, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC Encourages AL, FFWM, AKRO, HNI Shareholders to Contact the Firm to Discuss Their Rights

October 30, 2025

From Halper Sadeh LLC

Via GlobeNewswire

October 29, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC Investigates AKRO, CCRD, PBBK on Behalf of Shareholders

October 22, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE – AL)

October 22, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TRUE, AKRO, PCH, ATXS on Behalf of Shareholders

October 16, 2025

From Halper Sadeh LLC

Via GlobeNewswire

October 16, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Omeros Catapults Almost 150% On A Surprise $2.1 Billion Deal With Novo Nordisk ↗

October 15, 2025

Via Investor's Business Daily

Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO

October 10, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

October 10, 2025

Via Benzinga

Wall Street Pulls Back as Earnings Season Kicks Off; PepsiCo, Delta, and Costco Defy the Trend ↗

October 10, 2025

Via Chartmill

Why Akero Therapeutics Stock Trounced the Market on Thursday ↗

October 09, 2025

Via The Motley Fool

Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today ↗

October 09, 2025

Via Stocktwits

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates AKRO, CCRD, AL, PBBK on Behalf of Shareholders

October 09, 2025

From Halper Sadeh LLC

Via GlobeNewswire

October 09, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Tilray Brands Posts Upbeat Results, Joins Byrna Technologies, Delta Air Lines And Other Big Stocks Moving Higher On Thursday ↗

October 09, 2025

Via Benzinga

Novo Nordisk To Acquire Liver Disease Focused Akero Therapeutics For Around $5 Billion ↗

October 09, 2025

Via Benzinga

Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $4.7 Billion Buyout ↗

October 09, 2025

Via Investor's Business Daily

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 09, 2025

Via Benzinga

AKRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akero Therapeutics, Inc. Is Fair to Shareholders

October 09, 2025

From Halper Sadeh LLC

Via Business Wire

Frequently Asked Questions

Is Akero Therapeutics, Inc. - Common Stock publicly traded?

Yes, Akero Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Akero Therapeutics, Inc. - Common Stock trade on?

Akero Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Akero Therapeutics, Inc. - Common Stock?

The ticker symbol for Akero Therapeutics, Inc. - Common Stock is AKRO on the Nasdaq Stock Market

What is the current price of Akero Therapeutics, Inc. - Common Stock?

The current price of Akero Therapeutics, Inc. - Common Stock is 54.28

When was Akero Therapeutics, Inc. - Common Stock last traded?

The last trade of Akero Therapeutics, Inc. - Common Stock was at 11/24/25 03:39 PM ET

What is the market capitalization of Akero Therapeutics, Inc. - Common Stock?

The market capitalization of Akero Therapeutics, Inc. - Common Stock is 2.72B

How many shares of Akero Therapeutics, Inc. - Common Stock are outstanding?

Akero Therapeutics, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.